Mastodon

Gylan (Solvent) Instructions for Use

Therapeutic Category

A medical device for moisturizing and protecting the ocular mucosa.

Properties

It is a moisturizing ophthalmic agent. It is an isotonic (pH 6.0-7.5) buffered sterile solution containing hyaluronic acid in the form of sodium hyaluronate, which is a natural moisturizing substance with a high capacity for binding water.

Sodium hyaluronate has a smaller molecular size compared to hyaluronic acid, which allows the substance to penetrate tissues more easily and ensures the formation of a uniform, stable, and durable protective layer on the cornea without affecting visual acuity.

Hyaluronic acid (in the form of its sodium salt) possesses the necessary viscosity and adhesive properties towards the cornea. Due to these properties of hyaluronic acid, when the product is instilled into the eyes, a thin film forms on the anterior surface of the cornea, protecting the eye from drying out and relieving sensations of discomfort, dryness, fatigue, burning, and eye irritation. It effectively moisturizes and restores the healthy condition of the eye surface – the cornea and conjunctiva.

Scope of Application

For intensive and long-term eye moisturization in dry eye syndrome (with symptoms of discomfort, dryness, foreign body sensation – “sand in the eyes”, burning, irritation); when wearing all types of contact lenses to eliminate discomfort; after ophthalmic surgical operations, as well as in cases of corneal damage and injuries.

ICD codes

ICD-10 code Indication
H04.1 Other disorders of lacrimal gland (dry eye syndrome)
S05.0 Injury of conjunctiva and corneal abrasion without mention of foreign body
Z97.3 Presence of spectacles and contact lenses
ICD-11 code Indication
9A1Z Diseases of the lacrimal system, unspecified
NA06.4 Injury of conjunctiva or cornea without foreign body
QB51.Y Presence of other specified devices other than cardiac or vascular implants

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Solvent

Instill 1-2 drops into each eye. The product can be used several times a day as needed.

Side Effects

Allergic reactions are possible; when using a highly viscous solution form, an unpleasant feeling of eyelids sticking together may occur.

Contraindications

Hypersensitivity to the components of the medical device.

Special Instructions

This is not a medicinal product.

The product is not intended for internal use.

If adverse reactions associated with the use of the product occur, it is necessary to discontinue use of the medical device and consult a doctor.

When used concomitantly with ophthalmic medications, it is recommended to maintain an interval of at least 15 minutes between the instillation of this product and other eye drops.

Eye ointments/gels should be applied after instillation of this product.

The need to remove contact lenses depends on the specific dosage form used.

Storage Conditions

Store at 8°C (46°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Brand (or Active Substance), Marketing Authorisation Holder, Dosage Form

Marketing Authorization Holder

Grotex, LLC (Russia)

Dosage Forms

Bottle OTC Icon Gylan Comfort Moisturizing ophthalmic solution 0.18%: dropper-tubes 0.4 ml 10 or 90 pcs.
Moisturizing ophthalmic solution 0.18%: 10 ml bottle 1 pc.

Dosage Form, Packaging, and Composition

Moisturizing ophthalmic solution as a colorless, slightly viscous liquid, odorless.

1 ml
Sodium hyaluronate 1.8±0.36 mg

Excipients: sorbitol – 18 mg, disodium hydrogen phosphate dihydrate – 7.48 mg, sodium dihydrogen phosphate dihydrate – 2.83 mg, purified water – up to 1 ml.

0.4 ml – polyethylene or polypropylene dropper-tubes (10) – foil film bags (1) – cardboard packs.
0.4 ml – polyethylene or polypropylene dropper-tubes (30) – foil film bags (3) – cardboard packs.

Moisturizing ophthalmic solution as a colorless, slightly viscous liquid, odorless.

1 ml
Sodium hyaluronate 1.8±0.36 mg

Excipients: sorbitol – 22 mg, disodium hydrogen phosphate dihydrate – 9.14 mg, sodium dihydrogen phosphate dihydrate – 3.45 mg, purified water – up to 1 ml.

10 ml – plastic bottles (1) with a dropper dispenser – foil film bags (1) – cardboard packs.

Marketing Authorization Holder

Grotex, LLC (Russia)

Dosage Forms

Bottle OTC Icon Gylan Ultra comfort Moisturizing ophthalmic solution 0.3%: dropper tubes 0.4 ml 10 or 90 pcs.
Moisturizing ophthalmic solution 0.3%: 10 ml bottle 1 pc.

Dosage Form, Packaging, and Composition

Moisturizing ophthalmic solution as a colorless, slightly viscous liquid, odorless.

1 ml
Sodium hyaluronate 3±0.6 mg

Excipients: sorbitol – 18 mg, disodium hydrogen phosphate dihydrate – 7.48 mg, sodium dihydrogen phosphate dihydrate – 2.83 mg, purified water – up to 1 ml.

0.4 ml – polyethylene or polypropylene dropper-tubes (10) – foil film bags (1) – cardboard packs.
0.4 ml – polyethylene or polypropylene dropper-tubes (30) – foil film bags (3) – cardboard packs.

Moisturizing ophthalmic solution as a colorless, slightly viscous liquid, odorless.

1 ml
Sodium hyaluronate 3±0.6 mg

Excipients: sorbitol – 22 mg, disodium hydrogen phosphate dihydrate – 9.14 mg, sodium dihydrogen phosphate dihydrate – 3.45 mg, purified water – up to 1 ml.

10 ml – plastic bottles (1) with a dropper dispenser – foil film bags (1) – cardboard packs.

Table of Contents

→ TABLE OF CONTENTS